• 1. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 4. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 5. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?
  Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxylic acids

Recent Advances in the Study of 4-Pyridinecarboxylic acid, 1,2-ethanediyl ester (CAS: 72121-34-7)

4-Pyridinecarboxylic acid, 1,2-ethanediyl ester (CAS: 72121-34-7) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This compound, characterized by its pyridine core and ester linkage, has been the subject of recent investigations due to its potential applications in drug development and biochemical studies. The unique structural features of this molecule make it a promising candidate for various therapeutic and diagnostic applications.

Recent studies have focused on the synthesis and characterization of 4-Pyridinecarboxylic acid, 1,2-ethanediyl ester, with particular emphasis on its reactivity and stability under different conditions. Researchers have employed advanced spectroscopic techniques, including NMR and mass spectrometry, to elucidate its molecular structure and confirm its purity. These efforts are crucial for ensuring the reproducibility of experiments and the reliability of subsequent biological assays.

One of the key findings in recent literature is the role of 4-Pyridinecarboxylic acid, 1,2-ethanediyl ester as a building block in the synthesis of more complex pharmaceutical agents. Its ability to act as a linker or spacer in drug conjugates has been explored, with promising results in enhancing drug delivery and targeting efficiency. Additionally, its potential as a modulator of enzymatic activity has been investigated, opening new avenues for the development of enzyme inhibitors.

In the context of biomedical applications, 4-Pyridinecarboxylic acid, 1,2-ethanediyl ester has shown promise in the design of prodrugs. Prodrug strategies leverage the compound's ester functionality to improve the pharmacokinetic properties of active pharmaceutical ingredients. Recent studies have demonstrated its utility in enhancing the bioavailability and reducing the toxicity of certain therapeutic agents, making it a valuable tool in modern drug design.

Another area of interest is the compound's potential use in diagnostic imaging. Researchers have explored its incorporation into contrast agents for medical imaging techniques such as MRI and PET. The pyridine moiety's ability to coordinate with metal ions has been exploited to develop novel imaging probes with improved sensitivity and specificity. These advancements hold significant promise for early disease detection and monitoring.

Despite these promising developments, challenges remain in the large-scale production and application of 4-Pyridinecarboxylic acid, 1,2-ethanediyl ester. Issues such as scalability of synthesis, cost-effectiveness, and regulatory compliance need to be addressed to facilitate its transition from the laboratory to clinical use. Ongoing research aims to optimize synthetic routes and evaluate the compound's safety profile in preclinical models.

In conclusion, 4-Pyridinecarboxylic acid, 1,2-ethanediyl ester (CAS: 72121-34-7) represents a versatile and valuable compound in chemical biology and pharmaceutical research. Its unique structural properties and diverse applications make it a focal point of current investigations. Continued research efforts are expected to further elucidate its potential and overcome existing challenges, paving the way for its broader utilization in medicine and biotechnology.

• 1570-45-2(ethyl pyridine-4-carboxylate)
• 1007-48-3(4-Acetoxymethylpyridine)
• 7082-71-5(Isonicotinic anhydride)
• 2459-09-8(Methyl isonicotinate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)